Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 5/2012

01-10-2012

Rare (<1%) histological subtypes of renal cell carcinoma: an update

Authors: Alampady K. Shanbhogue, Raghunandan Vikram, Raj Mohan Paspulati, Gregory MacLennan, Sadhna Verma, Kumar Sandrasegaran, Srinivasa R. Prasad

Published in: Abdominal Radiology | Issue 5/2012

Login to get access

Abstract

Recent advances in genetics and pathology have allowed description of several new histological subtypes of renal cell carcinoma (RCC) as well as better characterization of other rare subtypes. We herein present a comprehensive review of taxonomy, epidemiology, pathology, imaging findings, and natural history of a wide spectrum of rare subtypes of RCCs that individually constitute <1% of all the RCCs.
Literature
1.
2.
Srigley JR, Delahunt B (2009) Uncommon and recently described renal carcinomas. Mod Pathol 22(Suppl 2):S2–S23CrossRefPubMed
3.
Fuzesi L, Cober M, Mittermayer C (1992) Collecting duct carcinoma: cytogenetic characterization. Histopathology 21:155–160CrossRefPubMed
4.
Bielsa O, Arango O, Corominas JM, Llado C, Gelabert-Mas A (1994) Collecting duct carcinoma of the kidney. Br J Urol 74:127–128CrossRefPubMed
5.
6.
Algaba F, Akaza H, Lopez-Beltran A, et al. (2011) Current pathology keys of renal cell carcinoma. Eur Urol 60:634–643CrossRefPubMed
7.
Diaz JI, Mora LB, Hakam A (1999) The Mainz classification of renal cell tumors. Cancer Control 6:571–579PubMed
8.
Prasad SR, Humphrey PA, Menias CO, et al. (2005) Neoplasms of the renal medulla: radiologic-pathologic correlation. Radiographics 25:369–380CrossRefPubMed
9.
Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics 26:1795–1806 (discussion 1806-1710)CrossRefPubMed
10.
Yoon SK, Nam KJ, Rha SH, et al. (2006) Collecting duct carcinoma of the kidney: CT and pathologic correlation. Eur J Radiol 57:453–460CrossRefPubMed
11.
Kennedy SM, Merino MJ, Linehan WM, et al. (1990) Collecting duct carcinoma of the kidney. Hum Pathol 21:449–456CrossRefPubMed
12.
Pickhardt PJ, Siegel CL, McLarney JK (2001) Collecting duct carcinoma of the kidney: are imaging findings suggestive of the diagnosis? AJR Am J Roentgenol 176:627–633CrossRefPubMed
13.
Tokuda N, Naito S, Matsuzaki O, et al. (2006) Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol 176:40–43 (discussion 43)CrossRefPubMed
14.
Srigley JR, Eble JN (1998) Collecting duct carcinoma of kidney. Semin Diagn Pathol 15:54–67PubMed
15.
Davis CJJr, Mostofi FK, Sesterhenn IA (1995) Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 19:1–11CrossRefPubMed
16.
Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y (2009) Complications associated with sickle cell trait: a brief narrative review. Am J Med 122:507–512CrossRefPubMed
17.
Simpson L, He X, Pins M, et al. (2005) Renal medullary carcinoma and ABL gene amplification. J Urol 173:1883–1888CrossRefPubMed
18.
19.
Blitman NM, Berkenblit RG, Rozenblit AM, Levin TL (2005) Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol 185:268–272CrossRefPubMed
20.
Watanabe IC, Billis A, Guimaraes MS, et al. (2007) Renal medullary carcinoma: report of seven cases from Brazil. Mod Pathol 20:914–920CrossRefPubMed
21.
Pirich LM, Chou P, Walterhouse DO (1999) Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma. J Pediatr Hematol Oncol 21:67–69CrossRefPubMed
22.
Rathmell WK, Monk JP (2008) High-dose-intensity MVAC for advanced renal medullary carcinoma: report of three cases and literature review. Urology 72:659–663CrossRefPubMed
23.
Ferlicot S, Allory Y, Comperat E, et al. (2005) Mucinous tubular and spindle cell carcinoma: a report of 15 cases and a review of the literature. Virchows Arch 447:978–983CrossRefPubMed
24.
Hes O, Hora M, Perez-Montiel DM, et al. (2002) Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology 41:549–555CrossRefPubMed
25.
Weber A, Srigley J, Moch H (2003) Mucinous spindle cell carcinoma of the kidney. A molecular analysis. Pathologe 24:453–459CrossRefPubMed
26.
Rakozy C, Schmahl GE, Bogner S, Storkel S (2002) Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol 15:1162–1171CrossRefPubMed
27.
Noon AP, Smith DJ, McAndrew P (2010) Magnetic resonance imaging characterization of a mucinous tubular and spindle cell carcinoma of the kidney detected incidentally during an ectopic pregnancy. Urology 75:247–248CrossRefPubMed
28.
Cossu-Rocca P, Eble JN, Delahunt B, et al. (2006) Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol 19:488–493CrossRefPubMed
29.
Dhillon J, Amin MB, Selbs E, et al. (2009) Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol 33:44–49CrossRefPubMed
30.
Kuroda N, Hes O, Michal M, et al. (2008) Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: a histological, immunohistochemical, ultrastructural and FISH study. Histol Histopathol 23:1517–1523PubMed
31.
Bulimbasic S, Ljubanovic D, Sima R, et al. (2009) Aggressive high-grade mucinous tubular and spindle cell carcinoma. Hum Pathol 40:906–907CrossRefPubMed
32.
Simon RA, di Sant’agnese PA, Palapattu GS, et al. (2008) Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation. Int J Clin Exp Pathol 1:180–184PubMedPubMedCentral
33.
Azoulay S, Vieillefond A, Paraf F, et al. (2007) Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch 451:905–909CrossRefPubMed
34.
Yang XJ, Zhou M, Hes O, et al. (2008) Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol 32:177–187CrossRefPubMed
35.
Amin MB, MacLennan GT, Gupta R, et al. (2009) Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol 33:384–392CrossRefPubMed
36.
Camparo P, Vasiliu V, Molinie V, et al. (2008) Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 32:656–670CrossRefPubMed
37.
38.
Argani P, Lui MY, Couturier J, et al. (2003) A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 22:5374–5378CrossRefPubMed
39.
Argani P, Olgac S, Tickoo SK, et al. (2007) Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 31:1149–1160CrossRefPubMed
40.
Wu A, Kunju LP, Cheng L, Shah RB (2008) Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes. Histopathology 53:533–544CrossRefPubMed
41.
Ramphal R, Pappo A, Zielenska M, Grant R, Ngan BY (2006) Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. Am J Clin Pathol 126:349–364CrossRefPubMed
42.
Argani P, Lal P, Hutchinson B, et al. (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27:750–761CrossRefPubMed
43.
Kato H, Kanematsu M, Yokoi S, et al. (2011) Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype. J Magn Reson Imaging 33:217–220CrossRefPubMed
44.
Geller JI, Argani P, Adeniran A, et al. (2008) Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer 112:1607–1616CrossRefPubMed
45.
Dunnill MS, Millard PR, Oliver D (1977) Acquired cystic disease of the kidneys: a hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol 30:868–877CrossRefPubMedPubMedCentral
46.
Farivar-Mohseni H, Perlmutter AE, Wilson S, et al. (2006) Renal cell carcinoma and end stage renal disease. J Urol 175:2018–2020 (discussion 2021)CrossRefPubMed
47.
Tickoo SK, Harik LR, dePeralta-Venturina MN, et al. (2006) Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 30:141–153CrossRefPubMed
48.
Nouh MA, Kuroda N, Yamashita M, et al. (2010) Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int 105:620–627CrossRefPubMed
49.
Schwarz A, Vatandaslar S, Merkel S, Haller H (2007) Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2:750–756CrossRefPubMed
50.
Kojima Y, Takahara S, Miyake O, et al. (2006) Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol 13:1045–1048CrossRefPubMed
51.
Bassal M, Mertens AC, Taylor L, et al. (2006) Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 24:476–483CrossRefPubMed
52.
Medeiros LJ, Palmedo G, Krigman HR, Kovacs G, Beckwith JB (1999) Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol 23:772–780CrossRefPubMed
53.
Picken MM (2005) The evolving concept of renal neoplasia: impact of emerging molecular and electron microscopic studies. Ultrastruct Pathol 29:277–282CrossRefPubMed
Metadata
Title
Rare (<1%) histological subtypes of renal cell carcinoma: an update
Authors
Alampady K. Shanbhogue
Raghunandan Vikram
Raj Mohan Paspulati
Gregory MacLennan
Sadhna Verma
Kumar Sandrasegaran
Srinivasa R. Prasad
Publication date
01-10-2012
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2012
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-011-9810-1

Other articles of this Issue 5/2012

Abdominal Radiology 5/2012 Go to the issue

OriginalPaper

Intrapancreatic accessory spleen: CT appearance and differential diagnosis

OriginalPaper

RETRACTED ARTICLE: Diagnosis of rejection after liver transplantation: use of phosphorus-31 magnetic resonance spectroscopy (31P-MRS)

OriginalPaper

Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings

OriginalPaper

Adolescent bariatric surgery

OriginalPaper

Imaging the pregnant patient with abdominal pain

OriginalPaper

Early phase detection of bile leak after hepatobiliary surgery: value of Gd-EOB-DTPA-enhanced MR cholangiography
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits